We found that VK2 directly binds to HSD17B4, but does not affect the expression of HSD17B4, to inhibit the proliferation of HCC cells by inhibiting the activation of Akt and MEK/ERK signaling pathways, leading to a decrease in STAT3 activation. Here, AKT1 is linked to hepatocellular carcinoma.